DJIA 18,128.79 48.65 0.27%
NASDAQ 5,103.57 11.49 0.23%
S&P 500 2,121.13 3.44 0.16%
market minute promo

Celgene (NASDAQ: CELG)

117.35 -1.36 (-1.15%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $117.35 -1.15%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $119.20
Previous Close $118.71
Daily Range $117.18 - $119.38
52-Week Range $69.88 - $129.06
Market Cap $93.9B
P/E Ratio 49.67
Dividend (Yield) $0.00 (0.0%)
Volume 2,086,542
Average Daily Volume 5,914,440
Current FY EPS $4.42




Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary Rss Feed

3 Mega-Cap Stocks That Shouldn't Pay a Dividend

Mega-cap stocks are generally profitable and overflowing with free cash, leading many to pay handsome dividends. However, these three mega-cap stocks aren't currently paying a dividend -- and if their management teams are smart, they'll keep it that way for many years to come!

AstraZeneca Falls on Q1 Earnings Decline, Reiterates View - Analyst Blog

The Real Value In MabVax May Be Partnerships Rather Than Pipeline

Biotech And Healthcare Investment: It's Not Your Father's Healthcare Sector Anymore

Short Sellers Become More Wary of Big Biotech

Benzinga's Weekend M&A Chatter

Trusty Horses; Tools, Pizza and Shoes: Jim Cramer's Best Blogs

Celgene Signals Bigger Immuno-Oncology Push Into Blood Cancers

AstraZeneca Inks Multiple Deals, Immuno-Oncology in Focus - Analyst Blog

Health Care Sector Update for 04/24/2015: CELG, EHTH, AERI

See More CELG News...

CELG's Top Competitors

CELG $117.35 (-1.15%)
Current stock: CELG
AMGN $165.74 (-1.29%)
Current stock: AMGN
GILD $104.01 (0.30%)
Current stock: GILD
$0.00 (0.00%)
Current stock: